AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)

Q: What does CUSIP 00288U106 represent in this 13F holders report?

CUSIP 00288U106 is the security identifier for ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share used to aggregate holder disclosures.

Q: How many institutions held ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share in Q1 2021?

82 institutional investors reported ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 00288U106

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Shares, no par value per share
Shares outstanding: 305,667,944
Total 13F shares: 71,121,706
Share change: +2,433,673
Total reported value: $2,415,006,720
Put/Call ratio: 72%
Price per share: $33.96
Number of holders: 82
Value change: +$64,105,935
Number of buys: 56
Number of sells: 31

Quarterly Holders Quick Answers

What is CUSIP 00288U106?
CUSIP 00288U106 identifies ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 00288U106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VIKING GLOBAL INVESTORS LP	13F	Company	6.3%	19,283,744	$775,978,000	—	31 Dec 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	3.4%	10,450,180	$420,515,000	—	31 Dec 2020	13F
ORBIMED ADVISORS LLC	13F	Company	2.7%	8,400,768	$338,047,000	—	31 Dec 2020	13F
SB Management Ltd	13F	Company	2.2%	6,767,190	$272,312,000	—	31 Dec 2020	13F
HARVARD MANAGEMENT CO INC	13F	Company	1.3%	4,105,095	$165,189,000	—	31 Dec 2020	13F
Alpha Wave Global, LP	13F	Company	1.2%	3,804,328	$153,086,000	—	31 Dec 2020	13F
Founders Fund VII Management, LLC	13F	Company	1.2%	3,773,530	$151,847,000	—	31 Dec 2020	13F
Capital World Investors	13F	Company	1.2%	3,639,423	$146,450,000	—	31 Dec 2020	13F
Capital International Investors	13F	Company	0.25%	750,000	$30,180,000	—	31 Dec 2020	13F
Duquesne Family Office LLC	13F	Company	0.22%	659,750	$26,548,000	—	31 Dec 2020	13F
HHLR ADVISORS, LTD.	13F	Company	0.2%	600,000	$24,144,000	—	31 Dec 2020	13F
MARSHALL WACE, LLP	13F	Company	0.17%	512,410	$20,620,000	—	31 Dec 2020	13F
Redmile Group, LLC	13F	Company	0.16%	500,000	$20,120,000	—	31 Dec 2020	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.15%	454,598	$18,293,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.14%	432,357	$17,398,000	—	31 Dec 2020	13F
Woodline Partners LP	13F	Company	0.14%	431,087	$17,347,000	—	31 Dec 2020	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.12%	365,000	$14,688,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	0.11%	350,417	$14,102,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.1%	308,143	$12,399,000	—	31 Dec 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.1%	300,000	$12,072,000	—	31 Dec 2020	13F
Logos Global Management LP	13F	Company	0.1%	300,000	$12,072,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	0.08%	258,600	$10,406,000	—	31 Dec 2020	13F
Alyeska Investment Group, L.P.	13F	Company	0.08%	250,000	$10,060,000	—	31 Dec 2020	13F
Matrix Capital Management Company, LP	13F	Company	0.08%	250,000	$10,060,000	—	31 Dec 2020	13F
Casdin Capital, LLC	13F	Company	0.07%	200,000	$8,048,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	190,106	$7,649,000	—	31 Dec 2020	13F
Polar Asset Management Partners Inc.	13F	Company	0.06%	175,000	$7,042,000	—	31 Dec 2020	13F
BAMCO INC /NY/	13F	Company	0.03%	99,621	$4,009,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.03%	96,556	$3,885,000	—	31 Dec 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.02%	55,000	$2,213,000	—	31 Dec 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.02%	50,000	$2,012,000	—	31 Dec 2020	13F
BROOKFIELD Corp /ON/	13F	Company	0.01%	45,754	$1,841,000	—	31 Dec 2020	13F
Pinz Capital Management, LP	13F	Company	0.01%	34,200	$1,376,000	—	31 Dec 2020	13F
ExodusPoint Capital Management, LP	13F	Company	0.01%	28,850	$1,161,000	—	31 Dec 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.01%	21,095	$849,000	—	31 Dec 2020	13F
Foresite Capital Management V, LLC	13F	Company	0.01%	20,000	$805,000	—	31 Dec 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.01%	20,000	$805,000	—	31 Dec 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	0.01%	17,541	$706,000	—	31 Dec 2020	13F
Bullseye Asset Management LLC	13F	Company	0.01%	17,299	$695,000	—	31 Dec 2020	13F
JANE STREET GROUP, LLC	13F	Company	0%	14,923	$601,000	—	31 Dec 2020	13F
Geneos Wealth Management Inc.	13F	Company	0.01%	20,710	$560,000	—	31 Dec 2020	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0%	10,000	$402,000	—	31 Dec 2020	13F
BRANDYWINE MANAGERS, LLC	13F	Company	0%	8,936	$360,000	—	31 Dec 2020	13F
TELEMUS CAPITAL, LLC	13F	Company	0%	8,000	$322,000	—	31 Dec 2020	13F
PEAK6 Investments LLC	13F	Company	0%	7,631	$307,000	—	31 Dec 2020	13F
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	13F	Company	0%	6,000	$246,600	—	31 Dec 2020	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	6,444	$236,000	—	31 Dec 2020	13F
Quantitative Systematic Strategies LLC	13F	Company	0%	5,274	$212,000	—	31 Dec 2020	13F
Point72 Hong Kong Ltd	13F	Company	0%	5,061	$204,000	—	31 Dec 2020	13F
Covalis Capital LLP	13F	Company	0%	5,000	$201,000	—	31 Dec 2020	13F

Institutional Holders of AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) as of Q1 2021

As of 31 Mar 2021, AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 71,121,706 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, SB Management Ltd, Capital World Investors, HARVARD MANAGEMENT CO INC, Founders Fund VII Management, LLC, Falcon Edge Capital, LP, CREDIT SUISSE AG/, and Capital International Investors. This page lists 82 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.